DAX6.693-1,4%  Dow12.801-0,7%  Euro1,3200-0,7% 
ESt502.481-1,7%  Nas2.904-0,8%  Öl117,6-0,9% 
TDax769,9-0,4%  Nikkei8.947-0,6%  Gold1.721-0,5% 
Home > Aktien > La Jolla Pharmaceutical Aktie > Nachrichten zu La Jolla Pharmaceutical

La Jolla Pharmaceutical Aktie [WKN: A0ESWX / ISIN: US5034593070]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
BörsenplätzeChartvergleichKursziele InsidertradesKnock-outsmyfinanzen
OrderbuchRealtime StuttgartRSS Feed im ForumFondsSenden
HistorischRealtime Push  IR-DatenAnleihen
handeln

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur La Jolla Pharmaceutical CoShs . Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

Newssuche

 GO 

ALLE Nachrichten zur La Jolla Pharmaceutical CoShs

20.01.12La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
13.04.11La Jolla Pharmaceutical Company Announces Reverse Stock Split
05.04.11La Jolla Pharmaceutical Company to Focus on Regenerative Medicine with the Acquisition of Novel Class of Compounds
05.04.11BCB Community Bank and Allegiance Community Bank to Merge
07.12.10La Jolla Pharmaceutical Company Announces Appointment of Dr. Bertrand C. Liang to Board of Directors
07.09.10La Jolla Pharmaceutical Company Provides Update on Search for Clinical Products to In-License or Acquire
25.05.10LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES FINANCING OF UP TO $16.3 MILLION
25.05.10Sterlite Industries (India) Limited Announcement Regarding Change in Equity to ADS Ratio
05.03.10La Jolla Pharmaceutical Announces Termination of Merger Agreement with Adamis Pharmaceuticals
03.03.10La Jolla Pharmaceutical Announces Delisting from Nasdaq and Failure to Get Stockholder Vote for Merger
01.03.10La Jolla Pharmaceutical Company Announces the Adjournment of Special Meeting of Stockholders
24.02.10La Jolla Pharmaceutical Company Provides Voting Update - More Votes Needed or La Jolla Will Likely Close
19.02.10La Jolla Pharmaceutical Company Provides Responses to Frequently Asked Questions about Merger Vote
16.02.10La Jolla Pharmaceutical Company Calls Urgent Special Meeting of Stockholders on February 26, 2010 to Vote on Merger
25.01.10La Jolla Pharmaceutical Company Receives Nasdaq Delisting Notice and Intends to Appeal Determination
22.12.09La Jolla Pharmaceutical Company Announces Filing of Joint Proxy Statement/Prospectus
07.12.09La Jolla Pharmaceutical Company Announces Signing of Definitive Merger Agreement With Adamis Pharmaceuticals
25.11.09La Jolla Pharmaceutical Company Announces the Adjournment of Special Meeting of Stockholders
16.11.09La Jolla Pharmaceutical Company Announces the Adjournment of Special Meeting of Stockholders
02.11.09La Jolla Pharmaceutical Company Announces the Adjournment of Special Meeting of Stockholders
15.10.09La Jolla Pharmaceutical Company to Seek Stockholder Approval of Dissolution
18.09.09La Jolla Pharmaceutical Company Receives Notice of Noncompliance with Nasdaq Stock Market Listing Requirement
08.04.09La Jolla Pharmaceutical Company Announces Going Concern Opinion and Receipt of Nasdaq Staff Deficiency Letter
19.02.09La Jolla Pharmaceutical Company Announces Reduction in Workforce and Evaluates Strategic Options
12.02.09La Jolla Pharmaceutical Company Announces Negative Results of Interim Efficacy Analysis for Riquent Phase 3 ASPEN Trial
05.02.09La Jolla Pharmaceutical Company to Present at BIO CEO & Investor Conference
18.12.08La Jolla Pharmaceutical Provides Update on Its Auction Rate Securities and Its Ongoing Riquent® Phase 3 "ASPEN” Lupus Trial
31.10.08La Jolla Pharmaceutical Company Reports Third Quarter and Year-to-Date Financial Results
18.09.08La Jolla Pharmaceutical Company to Present at UBS Global Life Sciences Conference
07.08.08La Jolla Pharmaceutical Company to Present at Canaccord Adams Global Growth Conference
04.08.08La Jolla Pharmaceutical Company Reports Second Quarter and Year-to-Date Financial Results
09.06.08La Jolla Pharmaceutical Company to Present at Needham Biotechnology and Medical Technology Conference
07.05.08La Jolla Pharmaceutical Company Announces Pricing of Common Stock and Warrant Unit Offering
01.05.08La Jolla Pharmaceutical Company Reports First Quarter Financial Results
23.04.08La Jolla Pharmaceutical Announces Positive 12-Month Interim Antibody Data and Provides Update for Ongoing Riquent(R) Phase 3 'ASPEN' Lupus Trial
17.03.08La Jolla Pharmaceutical Company Receives Audit Opinion Containing Going Concern Qualification
28.02.08La Jolla Pharmaceutical Company Reports Fourth Quarter and Year-End Financial Results
28.02.08La Jolla Pharmaceutical Company to Present at Susquehanna Financial Group Healthcare Conference
11.02.08La Jolla Pharmaceutical Company Reports Progress in International Phase 3 Riquent(R) Study
06.02.08La Jolla Pharmaceutical Company to Present at BIO CEO Investor Conference

Anzeige

ANZEIGE

 
Wie bewerten Sie diese Seite?
schlecht sehr gut
Aktien Prime Standard: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z DAX MDAX Dow Jones EuroStoxx

Kontakt - Impressum - Werben - Presse

finanzen.net als Startseite - Sitemap - Arbeiten bei finanzen.net - RSS-Feeds - Datenschutz - Disclaimer - Nutzungsbedingungen


Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Telekurs. Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. © 1999-2012 finanzen.net GmbH

News Aktien Kurslisten Analysen Devisen Dollarkurs Fonds Zertifikate Optionsscheine Anleihen Rohstoffe Aktien kaufen Portfolio Links Aktien China Währungsrechner Gold kaufen CFD Aktienkurse Ölpreis Leitzins Heizölpreis IPO Börsenkurse Lexikon